Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Idiopathic Pulmonary Fibrosis
Clinical trial register · Germany

Idiopathic Pulmonary Fibrosis Trials in Germany, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5050 matching records held by the registry are in this view. Synced 04 Nov 2026, 03:18 UTC
5050
Studies in scope
all four open statuses
2856
Recruiting now
open to new participants
986
Lead sponsors
across recruiting studies
Top sites
Löwenstein 1 München 1 Rosenheim 1 Essen 1 Coswig 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Boehringer Ingelheim2 Endeavor Biomedicines, Inc.1 Contineum Therapeutics1 United Therapeutics1 Bristol-Myers Squibb1 Clear sponsor filter
Site location
Löwenstein1 München1 Rosenheim1 Essen1 Coswig1
All 6 locations
Target enrolment
to

Idiopathic Pulmonary Fibrosis trials in Germany

1 of 5050 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
DrugTreprostinil
United Therapeutics
Phase 3
1,850
Löwenstein, München, Rosenheim, Essen, Coswig, Bad Berka
2022-09-06
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 4 November 2026. https://priyalifescience.com/clinical-trials-germany/condition/idiopathic-pulmonary-fibrosis

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,050 studies in total at the last sync on 04 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies listing the condition Idiopathic Pulmonary Fibrosis that also match the filters currently applied.

How many Idiopathic Pulmonary Fibrosis trials are recruiting in Germany?

0 of the 1 studies on this page are recruiting new participants as of the 04 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Idiopathic Pulmonary Fibrosis), 1 studies
PhaseStudiesRecruitingShare
Phase 310100%

Most active sponsors

Lead sponsors with the most studies (Idiopathic Pulmonary Fibrosis)
Lead sponsorStudiesRecruiting
United Therapeutics10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.